top of page

Quantify Care offers a revolutionary breast cancer early detection technology that is compact, accurate, convenient, and painless

Contact us below to get started or email us at

Thanks! We'll be in touch soon.


Background on breast cancer

  • Breast cancer is one of the biggest healthcare problems for women in the U.S.

  • 1 in 8 women will get breast cancer in their lifetimes

  • However, earl detection dramatically reduces the death and suffering from breast cancer:

    • If detected at stage 1: 98%+ chance of survival after 5 years, with low treatment costs​

    • If detected at stage 4: 22% chance of survival after 5 years, with very high treatment costs

Background on mammograms

  • Mammograms are the traditional breast cancer screening technology and have been essentially unchanged for 50+ years

  • >50% of US women avoid mammograms in spite of insurance coverage, because:

1. Mammograms result in painful compression of the breast

2. Mammograms have a miss rate of 21% and false positive rate of 13%

3. Mammography equipment is large and expensive (up to $500K), and so can only be deployed in intimidating and inconvenient locations like hospitals

4. Women wait on average 7-14 days for the results, which leads to anxiety

5. Because of side effects, they are only recommended for women above 50, and only once every 2 years

Quantify Care's Bexa technology

  • Quantify Care’s Bexa technology is the first effective innovation in breast cancer early detection in over 50 years, and is fully FDA-cleared and clinical trials are completed with George Washington University

  • It’s a device the size of a computer mouse connected to a tablet – not at all intimidating and highly portable

  • Because of its compact size, it can be deployed in clinics, offices, retail locations, etc.

  • Bexa exams are painless – only 1 lb. of gentle pressure on the breast (as opposed to painful compression from mammograms)

  • It has a miss rate of 11% (vs. 21% for mammograms)

  • It has a false positive rate of 4% with a concurrent ultrasound (vs. 13% for mammograms)

  • Requires only 15 minutes to complete an exam, which is performed by a trained Quantify Care ultrasound technician (does not require a doctor), and results are available immediately

  • Radiation-free with no side effects: every woman can be screened every year from any age (irrespective of if they are pregnant or have other health issues)

  • Bexa technology is effective for all women, including women with dense breast tissue

  • FDA cleared (new 510K issued in July 2019), with a dedicated CPT code (0422T)

Getting started

  • Quantify Care's Bexa technology is a great fit for retailers/ pharmacies, on-site and near-site clinics, and primary care clinics

  • Please contact us to get started

bottom of page